Functional and Structural Characterization of HIV-1 gp41 Ectodomain Regions in Phospholipid Membranes Suggests that the Fusion-active Conformation Is Extended

Journal of Molecular Biology

Volumn 364, Issue 5, 2006, Pages 1103-1117

  Korazim, Ofir ^a   Sackett, Kelly ^a   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

FTIR; HIV 1; membrane fusion; peptide lipid interaction; virus cell fusion

Indexed keywords

GLYCOPROTEIN GP 41; VIRUS PROTEIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; ATOMIC FORCE MICROSCOPY; BETA SHEET; BILAYER MEMBRANE; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; FLUORESCENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE STRUCTURE; MICROSCOPY; MOLECULAR MODEL; NONHUMAN; PHOSPHOLIPID MEMBRANE; POROSITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; SPECTROSCOPY; WILD TYPE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33751074984     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.08.091     Document Type: Article

References (67)

1. Verkleij A.J., Zwaal R.F., Roelofsen B., Comfurius P., Kastelijn D., and van Deenen L.L. The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim. Biophys. Acta 323 (1973) 178-193
2. Virtanen J.A., Cheng K.H., and Somerharju P. Phospholipid composition of the mammalian red cell membrane can be rationalized by a superlattice model. Proc. Natl Acad. Sci. USA 95 (1998) 4964-4969
3. Fadok V.A., Voelker D.R., Campbell P.A., Cohen J.J., Bratton D.L., and Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148 (1992) 2207-2216
4. Bevers E.M., Comfurius P., van Rijn J.L., Hemker H.C., and Zwaal R.F. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur. J. Biochem. 122 (1982) 429-436
5. Driesen R.B., Dispersyn G.D., Verheyen F.K., van den Eijnde S.M., Hofstra L., Thone F., et al. Partial cell fusion: a newly recognized type of communication between dedifferentiating cardiomyocytes and fibroblasts. Cardiovasc. Res. 68 (2005) 37-46
6. van den Eijnde S.M., van den Hoff M.J., Reutelingsperger C.P., van Heerde W.L., Henfling M.E., Vermeij-Keers C., et al. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J. Cell Sci. 114 (2001) 3631-3642
7. Gautier I., Coppey J., and Durieux C. Early apoptosis-related changes triggered by HSV-1 in individual neuronlike cells. Exp. Cell Res. 289 (2003) 174-183
8. Dalgleish A.G., Beverley P.C., Clapham P.R., Crawford D.H., Greaves M.F., and Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312 (1984) 763-767
9. Maddon P.J., Dalgleish A.G., McDougal J.S., Clapham P.R., Weiss R.A., and Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47 (1986) 333-348
10. Jones P.L., Korte T., and Blumenthal R. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J. Biol. Chem. 273 (1998) 404-409
11. Feng Y., Broder C.C., Kennedy P.E., and Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272 (1996) 872-877
12. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., and Berger E.A. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272 (1996) 1955-1958
13. Barbouche R., Miquelis R., Jones I.M., and Fenouillet E. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion. J. Biol. Chem. 278 (2003) 3131-3136
14. Veronese F.D., DeVico A.L., Copeland T.D., Oroszlan S., Gallo R.C., and Sarngadharan M.G. Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science 229 (1985) 1402-1405
15. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W.C., Terwilliger E., et al. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237 (1987) 1351-1355
16. Munoz-Barroso I., Durell S., Sakaguchi K., Appella E., and Blumenthal R. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J. Cell Biol. 140 (1998) 315-323
17. Chan D.C., Fass D., Berger J.M., and Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89 (1997) 263-273
18. Weissenhorn W., Dessen A., Harrison S.C., Skehel J.J., and Wiley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387 (1997) 426-430
19. Kozlov M.M., Leikin S.L., Chernomordik L.V., Markin V.S., and Chizmadzhev Y.A. Stalk mechanism of vesicle fusion. Intermixing of aqueous contents. Eur. Biophys. J. 17 (1989) 121-129
20. Chernomordik L.V., Melikyan G.B., and Chizmadzhev Y.A. Biomembrane fusion: a new concept derived from model studies using two interacting planar lipid bilayers. Biochim. Biophys. Acta 906 (1987) 309-352
21. LaBranche C.C., Galasso G., Moore J.P., Bolognesi D.P., Hirsch M.S., and Hammer S.M. HIV fusion and its inhibition. Antiviral. Res. 50 (2001) 95-115
22. Eckert D.M., and Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70 (2001) 777-810
23. Wild C., Greenwell T., and Matthews T. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res. Hum. Retroviruses 9 (1993) 1051-1053
24. Nieva J.L., Nir S., Muga A., Goni F.M., and Wilschut J. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage. Biochemistry 33 (1994) 3201-3209
25. Peisajovich S.G., Epand R.F., Pritsker M., Shai Y., and Epand R.M. The polar region consecutive to the HIV fusion peptide participates in membrane fusion. Biochemistry 39 (2000) 1826-1833
26. Sackett K., and Shai Y. The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion. Biochemistry 41 (2002) 4678-4685
27. Pascual R., Moreno M.R., and Villalain J. A peptide pertaining to the loop segment of human immunodeficiency virus gp41 binds and interacts with model biomembranes: implications for the fusion mechanism. J. Virol. 79 (2005) 5142-5152
28. Suarez T., Nir S., Goni F.M., Saez-Cirion A., and Nieva J.L. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence. FEBS Letters 477 (2000) 145-149
29. Shnaper S., Sackett K., Gallo S.A., Blumenthal R., and Shai Y. The C- and the N-terminal regions of glycoprotein 41 ectodomain fuse membranes enriched and not enriched with cholesterol, respectively. J. Biol. Chem. 279 (2004) 18526-18534
30. Markosyan R.M., Cohen F.S., and Melikyan G.B. HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation. Mol. Biol. Cell 14 (2003) 926-938
31. Dimitrov A.S., Louis J.M., Bewley C.A., Clore G.M., and Blumenthal R. Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation. Biochemistry 44 (2005) 12471-12479
32. Hamburger A.E., Kim S., Welch B.D., and Kay M.S. Steric accessibility of the HIV-1 gp41 N-trimer region. J. Biol. Chem. 280 (2005) 12567-12572
33. Kliger Y., Peisajovich S.G., Blumenthal R., and Shai Y. Membrane-induced conformational change during the activation of HIV-1 gp41. J. Mol. Biol. 301 (2000) 905-914
34. Rabenstein M., and Shin Y.K. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation. Biochemistry 34 (1995) 13390-13397
35. Kliger Y., Aharoni A., Rapaport D., Jones P., Blumenthal R., and Shai Y. Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study. J. Biol. Chem. 272 (1997) 13496-13505
36. Dubay J.W., Roberts S.J., Brody B., and Hunter E. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol. 66 (1992) 4748-4756
37. Pascual R., Contreras M., Fedorov A., Prieto M., and Villalain J. Interaction of a peptide derived from the N-heptad repeat region of gp41 Env ectodomain with model membranes. Modulation of phospholipid phase behavior. Biochemistry 44 (2005) 14275-14288
38. Deshayes S., Plenat T., Aldrian-Herrada G., Divita G., Le Grimellec C., and Heitz F. Primary amphipathic cell-penetrating peptides: structural requirements and interactions with model membranes. Biochemistry 43 (2004) 7698-7706
39. Sackett K., and Shai Y. The HIV fusion peptide adopts intermolecular parallel beta-sheet structure in membranes when stabilized by the adjacent N-terminal heptad repeat: a 13C FTIR study. J. Mol. Biol. 350 (2005) 790-805
40. Jameson D.M., and Sawyer W.H. Fluorescence anisotropy applied to biomolecular interactions. Methods Enzymol. 246 (1995) 283-300
41. Lu M., and Kim P.S. A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein. J. Biomol. Struct. Dynam. 15 (1997) 465-471
42. Epand R.M., Shai Y., Segrest J.P., and Anantharamaiah G.M. Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides. Biopolymers 37 (1995) 319-338
43. Wexler-Cohen Y., Sackett K., and Shai Y. The role of the N-terminal heptad repeat of HIV-1 in the actual lipid mixing step as revealed by its substitution with distant coiled coils. Biochemistry 44 (2005) 5853-5861
44. Gordon L.M., Curtain C.C., Zhong Y.C., Kirkpatrick A., Mobley P.W., and Waring A.J. The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation. Biochim. Biophys. Acta 1139 (1992) 257-274
45. Martin I., Defrise-Quertain F., Decroly E., Vandenbranden M., Brasseur R., and Ruysschaert J.M. Orientation and structure of the NH2-terminal HIV-1 gp41 peptide in fused and aggregated liposomes. Biochim. Biophys. Acta 1145 (1993) 124-133
46. Rafalski M., Lear J.D., and DeGrado W.F. Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41. Biochemistry 29 (1990) 7917-7922
47. Pereira F.B., Goni F.M., Muga A., and Nieva J.L. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects. Biophys. J. 73 (1997) 1977-1986
48. Yang J., Gabrys C.M., and Weliky D.P. Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane-bound HIV-1 fusion peptide. Biochemistry 40 (2001) 8126-81237
49. Sackett K., and Shai Y. How structure correlates to function for membrane associated HIV-1 gp41 constructs corresponding to the N-terminal half of the ectodomain. J. Mol. Biol. 333 (2003) 47-58
50. Arispe N. Architecture of the Alzheimer's A beta P ion channel pore. J. Membr. Biol. 197 (2004) 33-48
51. Arispe N., Pollard H.B., and Rojas E. Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc. Natl Acad. Sci. USA 90 (1993) 10573-10577
52. Thundimadathil J., Roeske R.W., Jiang H.Y., and Guo L. Aggregation and porin-like channel activity of a beta sheet peptide. Biochemistry 44 (2005) 10259-10270
53. Wild C.T., Shugars D.C., Greenwell T.K., McDanal C.B., and Matthews T.J. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl Acad. Sci. USA 91 (1994) 9770-9774
54. Jiang S., Lin K., Strick N., and Neurath A.R. HIV-1 inhibition by a peptide. Nature 365 (1993) 113
55. Poumbourios P., Wilson K.A., Center R.J., El Ahmar W., and Kemp B.E. Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence. J. Virol. 71 (1997) 2041-2049
56. Wild C., Dubay J.W., Greenwell T., Baird Jr. T., Oas T.G., McDanal C., et al. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl Acad. Sci. USA 91 (1994) 12676-12680
57. Chen S.S., Lee C.N., Lee W.R., McIntosh K., and Lee T.H. Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J. Virol. 67 (1993) 3615-3619
58. Chen S.S. Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 68 (1994) 2002-2010
59. Dimitrov A.S., Xiao X., Dimitrov D.S., and Blumenthal R. Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes. J. Biol. Chem. 276 (2001) 30335-30341
60. Merrifield R.B., Vizioli L.D., and Boman H.G. Synthesis of the antibacterial peptide cecropin A (1-33). Biochemistry 21 (1982) 5020-5031
61. Shai Y., Bach D., and Yanovsky A. Channel formation properties of synthetic pardaxin and analogues. J. Biol. Chem. 265 (1990) 20202-20209
62. Rapaport D., and Shai Y. Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. J. Biol. Chem. 266 (1991) 23769-23775
63. Struck D.K., Hoekstra D., and Pagano R.E. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20 (1981) 4093-4099
64. Yang T., Simanek E.E., and Cremer P. Creating addressable aqueous microcompartments above solid supported phospholipid bilayers using lithographically patterned poly(dimethylsiloxane) molds. Anal. Chem. 72 (2000) 2587-2589
65. Surewicz W.K., Mantsch H.H., and Chapman D. Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment. Biochemistry 32 (1993) 389-394
66. Vigano C., Goormaghtigh E., and Ruysschaert J.M. Detection of structural and functional asymmetries in P-glycoprotein by combining mutagenesis and H/D exchange measurements. Chem. Phys. Lipids 122 (2003) 121-135
67. Sackett K., Wexier-Cohen Y., and Shai Y. Characterization of the HIV N-terminal fusion peptide containing region in context of key gp41 fusion conformations. J. Biol. Chem. 281 (2006) 21755-21762